Clinical trials teams gathered in the RNSH foyer to celebrate International Clinical Trials Day
Celebrating the quiet achievers behind clinical trial success International Clinical Trials Day provided the chance to recognise the many people contributing to life-changing clinical trials. Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial staff behind the scenes whose expertise and commitment ensure our trials are run safely, ethically and with care. “At the heart of every breakthrough are the patients who generously volunteer to take part in clinical trials. We are deeply grateful for their contributions and participation.”
investigators, and a public display within the foyer of Royal North Shore Hospital involving teams from our trials workforce. More than 300 trials are underway across the district including innovative projects at Royal North Shore Hospital, Hornsby Ku-ring-gai, Ryde, Macquarie and Mona Vale hospitals. These trials are the key to medical progress, from the medications people take to the procedures and the technologies that improve lives. NSLHD Chief Executive Anthony Schembri thanked the large trials workforce for their commitment to our exceptional research. “At northern Sydney, the district is embedding trials as therapy, integrating them into standard care so that all patients have access to the very latest medical innovations,” he said. “We are building our world-class expertise, while extending our activity and capabilities. “I would like to recognise the hundreds of
The district is establishing a dedicated clinical trials centre to extend access to cutting-edge therapies. NORTH STAR will offer hope to millions of people with cancer and non-cancer related conditions. Head of the non-cancer stream Professor Rory Clifton-Bligh said NORTH STAR will bring together world-leading clinical trialists, delivering benefits for patients and the broader community. “These trials will continue to advance our understanding, develop new treatments, and improve how we prevent, diagnose and manage conditions,” he said. “NORTH STAR will expand the quality and quantity of our trials, nurture our trials workforce and strengthen partnerships with industry at all stages of the therapy pipeline. “It will offer access to leading specialists, the latest breakthroughs and high standards of care.”
Clinical trials Associate Professor Mark Montebello, Prof Rory Clifton Bligh, Rebecca Stevenson, Dr Eveline Staub and Professor Jeremy Booth
WWW.NSLHD.HEALTH.NSW.GOV.AU
171
Made with FlippingBook - professional solution for displaying marketing and sales documents online